Samsung Medical Center
| 大韓民国 | トルコ | オーストリア | |
| 神経芽細胞腫の複雑治療 | - | から $28,000 | から $180,000 |
Bookimedは神経芽腫治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。神経芽腫治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。神経芽腫治療の旅路でお一人になることはありません。
South Korean centers like Samsung Medical Center and Severance Hospital provide advanced neuroblastoma treatment. These facilities utilize MIBG-scintigraphy and multidisciplinary pediatric teams. High-volume tertiary hospitals in Seoul maintain Newsweek rankings and JCI accreditation. They often integrate bone marrow biopsies and specialized PORT-A-CATH installations.
Bookimed Expert Insight: Patient volume is a reliable proxy for expertise in rare pediatric cancers. Severance Hospital and Samsung Medical Center handle millions of patients annually. This scale ensures their surgical teams maintain high proficiency in complex neuroblastoma resections. These centers often have greater access to specific diagnostic tools like MIBG-scintigraphy compared to regional clinics.
Patient Consensus: Parents emphasize choosing large tertiary children centers in Seoul for high-risk cases. They note that specialized oncology teams in these major hubs offer better coordination for chemotherapy and transplants.
South Korea provides intensive multimodal treatment for high-risk neuroblastoma. Protocols include high-dose chemotherapy, surgical resection, and tandem autologous stem cell transplantation. Specialized centers like Samsung Medical Center utilize advanced immunotherapy with dinutuximab beta and Targeted 131I-MIBG therapy for metastatic cases.
Bookimed Expert Insight: South Korea is a leader in digital oncology. Samsung Medical Center and Seoul National University Bundang Hospital prioritize error-prevention systems like BESTcare. This digital infrastructure is critical for high-risk pediatric cases where medication dosing and infection monitoring require zero-margin accuracy during long 15-month protocols.
Patient Consensus: Families note that treatment is a long journey requiring significant local support for nutrition and infection control. Many emphasize that a second opinion from a major pediatric center is essential before starting the multi-step protocol.
International patients can enroll in neuroblastoma clinical trials in South Korea at major academic centers. Facilities like Samsung Medical Center participate in multinational studies for high-risk cases. Enrollment depends on specific protocol eligibility. The Ministry of Food and Drug Safety (MFDS) regulates these clinical collaborations.
Bookimed Expert Insight: Clinical trial access in Korea is concentrated in high-volume hubs like Seoul. Severance Hospital and Samsung Medical Center serve over 2,000,000 patients annually. This massive scale allows these centers to host diverse trials that smaller facilities cannot. Patients should focus on these Large-scale institutions to find the most active neuroblastoma protocols.
Patient Consensus: Parents emphasize that trial participation requires a long-term commitment to stay near the hospital. They note that having all pathology records ready speeds up the screening process significantly.
Iodine-131-MIBG therapy is available at specialized pediatric oncology centers in South Korea. Facilities like Samsung Medical Center in Seoul provide this targeted radiotherapy for high-risk neuroblastoma. Korean tertiary centers report a 70% 5-year survival rate using comprehensive protocols involving MIBG and stem cell transplantation.
Bookimed Expert Insight: Samsung Medical Center serves over 2,100,000 patients annually and maintains presidential standards. This high volume supports specialized nuclear medicine teams required for pediatric radiation. Their 1,900+ beds ensure capacity for the mandatory isolation periods needed during radioactive treatments.
Patient Consensus: Parents note that MIBG is only found at specific specialty hospitals. They emphasize the need to confirm tumor uptake and prepare for radiation-safety requirements during inpatient isolation.
International families should plan for a 12 to 18-month stay in Korea for complete high-risk neuroblastoma treatment. This extensive timeline covers induction chemotherapy, surgery, stem cell transplant, and immunotherapy. Most patients require a G-1 medical visa for stays exceeding 90 days.
Bookimed Expert Insight: Samsung Medical Center operates a 1,979-bed facility with massive patient volumes. This scale ensures high-risk protocols are routine rather than experimental. Families should prioritize hospitals with KOIHA accreditation to guarantee safety during the 18-month treatment cycle.
Patient Consensus: Parents note that treatment is not a single admission but multiple intensive stages. Staying near the hospital during the transplant phase is essential for managing recovery and isolation needs.
South Korean tertiary hospitals provide specialized support for non-Korean patients through dedicated International Healthcare Centers. These centers manage medical coordination, 24/7 interpretation, and logistical aid. Facilities like Samsung Medical Center offer specific pediatric support and family counseling for neuroblastoma cases.
Bookimed Expert Insight: Korea stands out globally because its top hospitals are massive medical complexes. Samsung Medical Center and Severance Hospital each serve over 1.5 million patients annually. This high volume means their international departments are exceptionally well-staffed and efficient. They handle everything from visa paperwork to airport pickups with clinical precision.
Patient Consensus: Parents recommend prioritizing university hospitals for neuroblastoma treatment. They note that having a dedicated English-speaking coordinator makes managing complex pediatric oncology schedules much easier.